Fennec Pharmaceuticals Inc. Common Stock
FENC •
Sell Open
Signal type
Sell
Status
Open
Open Price
$5.90
Stop Loss
$6.69
Performance
-5.93%
Days Open
22
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 24, 2026
Open Price $5.90
Stop Loss $6.69
Timespan Day
Company Profile
Name Fennec Pharmaceuticals Inc. Common Stock
Ticker FENC
Market Cap $235.86M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $6.25
List Date Jan 28, 2002
Description
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Website Open Company Website